01-11-2005 | Original Research Paper
Rosiglitazone, an agonist of peroxisome proliferator-activated receptor γ, reduces pulmonary inflammatory response in a rat model of endotoxemia
Published in: Inflammation Research | Issue 11/2005
Login to get access